Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | LOX | P28300 | 1/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3670805 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AGAA | |
| SCHEMBL148805 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AGAA | |
| SCHEMBL7926003 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AGAA | |
| SCHEMBL152123 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AGAA | |
| SCHEMBL9066848 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AGAA | |
| SCHEMBL7986742 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AGAA | |
| SCHEMBL9066931 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AGAA | |
| SCHEMBL8850903 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AGAA | |
| SCHEMBL21634 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AGAA | |
| SCHEMBL10476209 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015117243-A1 | LIQUID FORMULATION FOR E-CIGARETTES | BELLEROSE SAMUEL (CA) | 2015-08-13 | — | — | WO | claimed |
| US-4155900-A | REPLACING DIPENTAERYTHRITOL WITH ETHERIFIED POLYOL | PHILLIPS PETROLEUM COMPANY (US) | 1979-05-22 | — | — | US | claimed |
| US-20230302463-A1 | FROTHING AGENT FOR FLOTATION OF ORES | BASF SE (DE) | 2023-09-28 | — | — | US | disclosed |
| WO-2023120726-A1 | WEAK-ANCHORING LIQUID CRYSTAL ALIGNMENT AGENT, AND LIQUID CYRSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2023-06-29 | — | — | WO | disclosed |
| US-20210045311-A1 | PROPYL CANNABINOID HEMP PLANTS, METHODS OF PRODUCING AND METHODS OF USING THEM | BIOTECH INST LLC (US) | 2021-02-18 | — | — | US | disclosed |
| US-20200405685-A1 | HIGH CANNABIGEROL CANNABIS PLANTS, METHODS OF PRODUCING AND METHODS OF USING THEM | BIOTECH INST LLC (US) | 2020-12-31 | — | — | US | disclosed |
| EP-3720426-A1 | HIGH CANNABIGEROL CANNABIS PLANTS, METHODS OF PRODUCING AND METHODS OF USING THEM | Biotech Institute, LLC (US) | 2020-10-14 | — | — | EP | disclosed |
| EP-3720275-A1 | PROPYL CANNABINOID HEMP PLANTS, METHODS OF PRODUCING AND METHODS OF USING THEM | Biotech Institute, LLC (US) | 2020-10-14 | — | — | EP | disclosed |
| EP-3541169-A1 | CARYOPHYLLENE COMPOSITIONS, APPARATUSES, AND METHODS | Biotech Institute, LLC (US) | 2019-09-25 | — | — | EP | disclosed |
| WO-2019113582-A1 | SPECIALTY PLANTS AND CANNABINOID COMPOSITIONS COMPRISING HEXYL BUTYRATE | Biotech Institute LLC (US) | 2019-06-13 | — | — | WO | disclosed |
| WO-2019113497-A1 | HIGH CANNABIGEROL CANNABIS PLANTS, METHODS OF PRODUCING AND METHODS OF USING THEM | Biotech Institute LLC (US) | 2019-06-13 | — | — | WO | disclosed |
| US-20100087567-A1 | EPOXY GROUP-TERMINATED POLYMERS, THE COMPOSITIONS THEREOF AND THE USE THEREOF AS IMPACT RESISTANCE MODIFIERS | SIKA TECHNOLOGY AG (CH) | 2010-04-08 | — | — | US | disclosed |
| US-7045490-B2 | Refrigerating machine oil composition | NIPPON OIL CORPORATION (JP) | 2006-05-16 | — | — | US | disclosed |
| US-20030166478-A1 | Refrigerating machine oil composition | NIPPON OIL CORPORATION (JP) | 2003-09-04 | — | — | US | disclosed |
| US-4638097-A | Reducing the content of cyclic oligomeric ethers in polytetramethylene ether glycols or polyoxybutylene polyoxyalkylene glycols | BASF AKTIENGESELLSCHAFT (DE) | 1987-01-20 | — | — | US | disclosed |
| US-4159277-A | Zwitterionic compounds with a tetramethylene oxide moiety between the cationic and anionic charge centers | THE PROCTER & GAMBLE COMPANY (US) | 1979-06-26 | — | — | US | disclosed |
| US-4155900-A | REPLACING DIPENTAERYTHRITOL WITH ETHERIFIED POLYOL | PHILLIPS PETROLEUM COMPANY (US) | 1979-05-22 | — | — | US | disclosed |
| US-4000091-A | ZWITTERIONIC SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-4000092-A | ZWITTERIONIC SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-3943189-A | Process for preparation of copolymers from polyesters and aliphatic polyformals | EASTMAN KODAK COMPANY (US) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210045311-A1 | PROPYL CANNABINOID HEMP PLANTS, METHODS OF PRODUCING AND METHODS OF USING THEM | CNR2, CNR1, PLCB3 | TSHR 3696/4885MAPK1 3715/4885MEN1 4668/4885 |
| US-20200405685-A1 | HIGH CANNABIGEROL CANNABIS PLANTS, METHODS OF PRODUCING AND METHODS OF USING THEM | CNR2, CNR1, PLCG2 | TSHR 4619/4885MAPK1 3303/4885MEN1 4584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.